328 related articles for article (PubMed ID: 35659360)
1. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.
Liu QW; Ying YM; Zhou JX; Zhang WJ; Liu ZX; Jia BB; Gu HC; Zhao CY; Guan XH; Deng KY; Xin HB
Stem Cell Res Ther; 2022 Jun; 13(1):224. PubMed ID: 35659360
[TBL] [Abstract][Full Text] [Related]
2. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
[TBL] [Abstract][Full Text] [Related]
3. Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice.
Liu QW; Li JY; Zhang XC; Liu Y; Liu QY; Xiao L; Zhang WJ; Wu HY; Deng KY; Xin HB
J Cell Mol Med; 2020 Sep; 24(18):10525-10541. PubMed ID: 32798252
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
5. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway.
Rong X; Liu J; Yao X; Jiang T; Wang Y; Xie F
Stem Cell Res Ther; 2019 Mar; 10(1):98. PubMed ID: 30885249
[TBL] [Abstract][Full Text] [Related]
8. Human amniotic MSCs-mediated anti-inflammation of CD206
Huang QM; Long YL; Wang JN; Wu J; Tang WL; Wang XY; Zhang ZH; Zhuo YQ; Guan XH; Deng KY; Xin HB
Int Immunopharmacol; 2024 Mar; 129():111660. PubMed ID: 38350357
[TBL] [Abstract][Full Text] [Related]
9. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats.
Pietrosi G; Fernández-Iglesias A; Pampalone M; Ortega-Ribera M; Lozano JJ; García-Calderó H; Abad-Jordà L; Conaldi PG; Parolini O; Vizzini G; Luca A; Bosch J; Gracia-Sancho J
Liver Int; 2020 Oct; 40(10):2500-2514. PubMed ID: 32996708
[TBL] [Abstract][Full Text] [Related]
10. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.
Chen Y; Chen X; Ji YR; Zhu S; Bu FT; Du XS; Meng XM; Huang C; Li J
J Cell Mol Med; 2020 Jul; 24(13):7405-7416. PubMed ID: 32463161
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of annexin A1/N-formylpeptide receptor regulation of macrophage function to inhibit hepatic stellate cell activation through Wnt/β-catenin pathway.
Fan JH; Luo N; Liu GF; Xu XF; Li SQ; Lv XP
World J Gastroenterol; 2023 Jun; 29(22):3422-3439. PubMed ID: 37389234
[TBL] [Abstract][Full Text] [Related]
12. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
13. Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway.
Wang C; Liu Y; Gong L; Xue X; Fu K; Ma C; Li Y
Inflammation; 2023 Aug; 46(4):1543-1560. PubMed ID: 37219693
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells can repair radiation-induced pulmonary fibrosis via a DKK-1-mediated Wnt/β-catenin pathway.
Shao L; Zhang Y; Shi W; Ma L; Xu T; Chang P; Dong L
Cell Tissue Res; 2021 Apr; 384(1):87-97. PubMed ID: 33496879
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
18. Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
Cheng C; Wang Q; Huang Y; Xue Q; Wang Y; Wu P; Liao F; Miao C
J Ethnopharmacol; 2023 Jul; 311():116445. PubMed ID: 37015279
[TBL] [Abstract][Full Text] [Related]
19. Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells.
Fu Q; Ohnishi S; Sakamoto N
Stem Cells Int; 2018; 2018():4898152. PubMed ID: 30402110
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]